Evidence map›Paper›PMID 29546996›Full record

ArticleAmerican journal of respiratory and critical care medicine2018

Future Research Directions in Pneumonia. NHLBI Working Group Report.

Charles S Dela Cruz, Richard G Wunderink, David C Christiani, Stephania A Cormier, Kristina Crothers, Claire M Doerschuk, Scott E Evans, Daniel R Goldstein, Purvesh Khatri, Lester Kobzik and 19 more

Abstract read
In one paragraph

Article in American journal of respiratory and critical care medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed, 1 pooled it
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 1 synthesis or guideline pooled it, 86 citations in OpenAlex.

  1. Human genetic factors associated with pneumonia risk, a cue for COVID-19 susceptibility.Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases · 2022
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Observational
  12. Article
  13. Review
  14. Article
  15. Immune mediators in heart-lung communication.Pflugers Archiv : European journal of physiology · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 1 country.

Charles S Dela Cruz1 Pulmonary, Critical Care and Sleep Medicine, Center for Pulmonary Infection Research and Treatment, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut.
Richard G Wunderink2 Pulmonary and Critical Care, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
David C Christiani3 Department of Environmental Health, Harvard T. H. Chan School of Public Health, and.
Stephania A Cormier5 Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana.
Kristina Crothers6 Department of Medicine, University of Washington, Seattle, Washington.
Claire M Doerschuk7 Marsico Lung Institute and.
Scott E Evans9 Department of Pulmonary Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas.
Daniel R Goldstein10 Department of Internal Medicine.
Purvesh Khatri13 Center for Biomedical Information Research, Stanford University, Stanford, California.
Lester Kobzik3 Department of Environmental Health, Harvard T. H. Chan School of Public Health, and.
Jay K Kolls14 Center for Translational Research in Infection and Inflammation, Tulane School of Medicine, New Orleans, Louisiana.
Bruce D Levy15 Pulmonary and Critical Care Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Mark L Metersky16 Division of Pulmonary, Critical Care and Sleep Medicine, University of Connecticut School of Medicine, Farmington, Connecticut.
Michael S Niederman17 Pulmonary and Critical Care Medicine, Department of Medicine, Weill Cornell Medicine, New York, New York.
Roomi Nusrat18 Department of Medicine, Rutgers Robert Wood Johnson School of Medicine, New Brunswick, New Jersey.
Carlos J Orihuela19 Department of Microbiology, University of Alabama at Birmingham, Birmingham, Alabama.
Paula Peyrani20 Division of Infectious Diseases, Department of Medicine, University of Louisville, Louisville, Kentucky.
Alice S Prince21 Department of Pediatrics, Columbia University, New York, New York.
Julio A Ramírez20 Division of Infectious Diseases, Department of Medicine, University of Louisville, Louisville, Kentucky.
Karen M Ridge2 Pulmonary and Critical Care, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Sanjay Sethi22 Pulmonary, Critical Care and Sleep Medicine, Jacobs School of Medicine, University at Buffalo, State University of New York, Buffalo, New York.
Benjamin T Suratt23 Pulmonary and Critical Care Medicine, University of Vermont College of Medicine, Burlington, Vermont.
Jacob I Sznajder2 Pulmonary and Critical Care, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Ephraim L Tsalik24 Emergency Medicine Service, Durham Veterans Affairs Health Care System, Durham, North Carolina.
Allan J Walkey26 Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts.
Sachin Yende27 Department of Critical Care Medicine, Clinical Research, Investigation, and Systems Modeling of Acute Illness Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
Neil R Aggarwal29 Division of Lung Diseases, NHLBI, NIH, Bethesda, Maryland.
Elisabet V Caler29 Division of Lung Diseases, NHLBI, NIH, Bethesda, Maryland.
Joseph P Mizgerd26 Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts.
Northwestern University · USBoston University · USNational Institutes of Health · USUniversity of Louisville · USBrigham and Women's Hospital · USColumbia University · USCornell University · USDuke University · USHarvard University · USLouisiana State University · USRutgers, The State University of New Jersey · USStanford University · USThe University of Texas MD Anderson Cancer Center · USTulane University · USUniversity at Buffalo, State University of New York · USUniversity of Alabama at Birmingham · USUniversity of Connecticut · USUniversity of Michigan · USUniversity of North Carolina at Chapel Hill · USUniversity of Pittsburgh · US

Funding

Role of LUBAC and Na K-ATPase in Acute Lung InjuryP01HL071643 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI SZNAJDER, JACOB I · 2003 to 2019
$30.8M
The HSPH Education and Research Center of Occupational Safety and HealthT42OH008416 · OH · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI CHRISTIANI, DAVID C · 2005 to 2025
$30.5M
Tissue resident macrophages regulate proteostasis in the aging lungP01AG049665 · NIA · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Alexander Misharin · 2015 to 2026
$26.9M
Resolution Mechanisms in Acute Inflammation: Resolution PharmacologyP01GM095467 · NIGMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SERHAN, CHARLES NICHOLAS · 2011 to 2020
$14.8M
The Role of IL4R Alpha in Neonatal RSV ImmunopathologyR01AI090059 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CORMIER, STEPHANIA A · 2011 to 2025
$6.7M
Pneumonia BiologyR35HL135756 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI MIZGERD, JOSEPH P · 2017 to 2023
$6.6M
Cardiac microlesion formation during invasive pneumococcal diseaseR01AI114800 · NIAID · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI Carlos J Orihuela, Herve S TETTELIN · 2015 to 2026
$5.1M
Combustion Generated PM0.1 and Predisposition to AsthmaR01ES015050 · NIEHS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI CORMIER, STEPHANIA A · 2006 to 2022
$4.6M
Inducible epithelial antiviral resistance to prevent asthmaDP2HL123229 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI EVANS, SCOTT E. · 2013 to 2013
$2.4M
Host-Pneumococcal Interaction in the LungR01HL126094 · NHLBI · YALE UNIVERSITY · PI DELA CRUZ, CHARLES S · 2015 to 2019
$2.1M
Epithelial mechanisms of inducible resistance to AML-associated pneumoniaR01HL117976 · NHLBI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI EVANS, SCOTT E. · 2014 to 2018
$2.0M
Monitoring peripheral blood leukocyte and immune responses in health and diseaseU24AI118656 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI LEVY, BRUCE D, VOLDMAN, JOEL · 2015 to 2019
$1.9M
6 · The paper itself

Abstract

Pneumonia is a complex pulmonary disease in need of new clinical approaches. Although triggered by a pathogen, pneumonia often results from dysregulations of host defense that likely precede infection. The coordinated activities of immune resistance and tissue resilience then dictate whether and how pneumonia progresses or resolves. Inadequate or inappropriate host responses lead to more severe outcomes such as acute respiratory distress syndrome and to organ dysfunction beyond the lungs and over extended time frames after pathogen clearance, some of which increase the risk for subsequent pneumonia. Improved understanding of such host responses will guide the development of novel approaches for preventing and curing pneumonia and for mitigating the subsequent pulmonary and extrapulmonary complications of pneumonia. The NHLBI assembled a working group of extramural investigators to prioritize avenues of host-directed pneumonia research that should yield novel approaches for interrupting the cycle of unhealthy decline caused by pneumonia. This report summarizes the working group's specific recommendations in the areas of pneumonia susceptibility, host response, and consequences. Overarching goals include the development of more host-focused clinical approaches for preventing and treating pneumonia, the generation of predictive tools (for pneumonia occurrence, severity, and outcome), and the elucidation of mechanisms mediating immune resistance and tissue resilience in the lung. Specific areas of research are highlighted as especially promising for making advances against pneumonia.

Indexed as

Research ReportAdultAgedAged, 80 and overBacterial InfectionsCongresses as TopicDisease SusceptibilityFemaleHost Microbial InteractionsHumansLungMaleMiddle AgedNational Heart, Lung, and Blood Institute (U.S.)PneumoniaRespiratory Distress Syndromebacterial infectionhost responsehost susceptibilitypneumoniaviral infection

Identifiers

PMID29546996
PMCPMC6058989
OpenAlexW2793619072

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.